|Videos|May 10, 2021
Increased Risk of Tardive Dyskinesia
Author(s)John J. Miller, MD
How could drugs that block post-synaptic dopamine 2 receptors increase the risk for tardive dyskinesia over time?
Advertisement
John J. Miller, MD, talks about the increased risk of tardive dyskinesia on a synaptic level.
Dr Miller is medical director, Brain Health, Exeter, NH; editor in chief, Psychiatric TimesTM; staff psychiatrist, Seacoast Mental Health Center, Exeter, NH; consulting psychiatrist, Exeter Hospital, Exeter, NH; consulting psychiatrist, Insight Meditation Society, Barre, MA.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
DT120 (Lysergide) Shows Rapid, Lasting Relief for Generalized Anxiety in Phase 3 Trial
2
Experience With Xanomeline/Trospium in an Acute Inpatient Setting Treating Individuals With Schizophrenia
3
FDA Approves Tauklarify (MK-6240) For Tau Pathology Detection in Alzheimer Disease
4
New Ingrezza Data Shows Improved Quality of Life and Daily Functioning in Tardive Dyskinesia
5